Global Blood Therapeutics, Inc.

Headquarters: South San Francisco, CA, United States

Employees: 457

CEO: Dr. Ted W. Love


Market Cap

$4.62 Billion

USD as of Oct. 1, 2022

history Market Cap History

Global Blood Therapeutics, Inc. market capitalization over time

Evolution of Global Blood Therapeutics, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Global Blood Therapeutics, Inc.

Detailed Description

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.

Top 1-year algo backtest: +240.10%

$10,000 in February 2023 would now be $34,010 by following it 5 minutes per day at market close.

How much did you gain in the last 12 months?

Stocks & Indices

Global Blood Therapeutics, Inc. has the following listings and related stock indices.

Stock: NASDAQ: GBT wb_incandescent

Stock: FSX: G5B wb_incandescent



171 Oyster Point Boulevard

Suite 300

South San Francisco, CA 94080

United States

Phone: 650 741 7700